N-Me-DL-Val-OH

N-Me-DL-Val-OH is an N-methylated valine amino acid (DL mixture) featuring a stereogenic α-carbon, a branched isopropyl side chain, and a free carboxylic acid that remains available for coupling or derivatization. The N-methyl group reduces the basicity of the amide-forming nitrogen and changes peptide-bond formation behavior relative to unmodified valine, making it a useful chiral and protection strategy element in peptide chemistry planning. As an amino acid with a free acid and a substituted amino nitrogen, N-Me-DL-Val-OH participates in standard amino acid activation chemistry while also serving as a precursor for amide, ester, and carbamate derivatives. The DL stereochemical composition supports racemic intermediate workflows where stereochemical resolution or downstream stereoselective steps can be applied as needed.

1. Peptide Synthesis

N-Me-DL-Val-OH is used in peptide synthesis workflows where incorporation of an N-methylated valine residue is required to probe backbone conformational effects and amide nitrogen substitution patterns. The compound's α-amino functionality is N-methylated, while the carboxylic acid enables activation and coupling to activated carboxyl derivatives or peptide fragments under common peptide coupling conditions. The presence of the branched valine side chain supports straightforward alignment with valine-containing sequences, including peptide analogs where N-methylation is used to modulate hydrogen-bonding capacity. Racemic (DL) stereochemistry can be employed for library synthesis, followed by stereochemical refinement in downstream analog selection and characterization. N-Me-DL-Val-OH thus functions as a practical amino acid building block for N-substituted peptide construction and peptide chemistry intermediate preparation.

2. Peptidomimetics And SAR Studies

N-Me-DL-Val-OH is applied in peptidomimetic design and structure-activity relationship studies where N-methylation of the valine residue is a common tactic to tune conformational bias and proteolytic stability proxies. The N-methylated nitrogen and carboxylic acid enable formation of amide linkages that preserve the valine side-chain topology while altering backbone donor/acceptor patterns. The isopropyl side chain supports mapping of hydrophobic contacts in SAR panels, and the racemic nature can facilitate rapid generation of stereochemical variants for subsequent separation or computational/experimental prioritization. Derivatives such as N-methyl amide analogs, ester-modified fragments, or protected forms can be prepared to support iterative analog synthesis. N-Me-DL-Val-OH therefore serves as an amino acid derivatization input for downstream peptidomimetic scaffold generation and SAR-focused molecular design.

3. Chemical Biology Labeling

N-Me-DL-Val-OH is suitable for chemical biology and biomolecular labeling strategies that require amino acid-derived handles for conjugation chemistry. The free carboxylic acid can be converted into activated ester or amide-forming derivatives to connect the N-methyl-valine motif to targeting ligands, linkers, or reporter-bearing scaffolds. The N-methyl substitution can influence reactivity and stability of the resulting conjugate by changing hydrogen-bonding and amide accessibility compared with unmodified valine residues. DL stereochemistry can be acceptable when labeling aims focus on chemical attachment rather than strict stereochemical fidelity, or when stereoisomers will be separated after conjugate formation. N-Me-DL-Val-OH thus supports amino acid-based intermediate preparation for conjugation-ready building blocks used in chemical probe synthesis.

4. Protected Amino Acid Derivatives

N-Me-DL-Val-OH is used as a starting material for preparing N-methylated protected amino acid derivatives and coupling-ready intermediates for synthetic organic chemistry. The combination of N-methyl substitution and a free carboxylic acid allows selective functional group management, including conversion of the acid to esters for temporary protection during multi-step sequences, or activation for direct peptide coupling. N-protection is inherently present via the methyl group, enabling strategies that focus on C-terminal protection and later deprotection to align with peptide assembly schedules. Racemic stereochemistry can be leveraged in process development where stereochemical resolution is deferred to a later stage, such as chiral purification of selected analogs. N-Me-DL-Val-OH therefore functions as a practical chiral amino acid intermediate precursor for protected amino acid synthesis and downstream peptide building block preparation.

5. Process Chemistry Intermediate

N-Me-DL-Val-OH is applicable to process chemistry intermediate preparation for industrial and fine-chemical manufacturing routes that incorporate N-methylated amino acid units into larger molecules. The stable amino acid framework with a free carboxylic acid supports conversion into activated forms used for stepwise assembly, while the N-methyl group can reduce side reactions associated with unprotected amino nitrogens under certain synthetic conditions. The branched valine side chain is chemically robust and compatible with common protecting-group strategies that manage only the carboxyl functionality during manufacturing sequences. DL composition can be advantageous for cost-effective intermediate supply when downstream steps include stereoselective separation, enzymatic resolution, or stereospecific incorporation at later stages. N-Me-DL-Val-OH thus serves as an amino acid-based intermediate for industrial synthesis planning, including peptide analog production and specialty chemical manufacturing where N-methylated residues are required.

1. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

2. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in inter-peptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling

3. TMEM16F and dynamins control expansive plasma membrane reservoirs

4. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes

5. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII